NKure Therapeutics and CRISPR Therapeutics Partner to Bring Off-the-Shelf CAR T Therapy CTX112™ to India for B-Cell Cancers
BENGALURU: NKure Therapeutics Private Limited, a Bengaluru-based biotech innovator, and CRISPR Therapeutics (Nasdaq: CRSP), a global leader in gene-based medicines, today announced a strategic partnership to co-develop and commercialize CTX112™,…
Read more